Skip to Main Content

Vaccines

The latest stories related to vaccines, including development and production issues.

Latest

Health Helen Branswell

RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC

Health Helen Branswell

FDA advisory panel recommends a streamlined flu vaccine for next fall

The Readout Damian Garde

STAT Plus: The next act for a biotech rainmaker

Health Andrew Joseph

Amid measles outbreaks, U.K. launches vaccination ad campaign to boost childhood immunizations

Health Annalisa Merelli

Cholera vaccine shortage reaches worst point yet, with experts fearing deadly outbreaks

The Readout Damian Garde

STAT Plus: The FDA isn’t afraid to yank a disappointing drug

Health Helen Branswell

Florida policy set amid measles outbreak alarms vaccination proponents

Pharmalot Ed Silverman

STAT Plus: Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $475 million

All Coverage

The Readout Meghana Keshavan

STAT Plus: Replicate’s srRNA rabies vaccine effective in Phase 1

The Readout Meghana Keshavan

STAT Plus: The need to know biotech news stories today

advertisement

Health Helen Branswell

Ebola vaccine cuts fatality even in people who were infected before the jab, new study shows

The Readout Meghana Keshavan

STAT Plus: Does Moderna’s RSV vaccine lose efficacy faster than others?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more

Adam's Take Adam Feuerstein

STAT Plus: A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys

D.C. Diagnosis Rachel Cohrs

New pharma CEOs in the hot seat

Exclusive Helen Branswell

STAT Plus: HHS leaves vacant more than half the slots on a key vaccine advisory panel

Health Helen Branswell

Updated Covid vaccine has 54% effectiveness, new data suggest

The Readout Damian Garde

Novavax is on thin ice, and the latest update isn’t exactly encouraging

Politics Sarah Owermohle

Congressmen: This Covid hearing ‘could have been an email’

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: Vaccines save lives and generate profits. Why is investment lagging?

Health Helen Branswell

Why many more people are lining up for a flu shot than a Covid vaccine

Health Andrew Joseph

Rollout of a new malaria vaccine kicks off in Africa

The Readout Meghana Keshavan

STAT Plus: The four biotech stories you need to read this morning

Health Helen Branswell

The WHO and drug regulators want to reformulate the flu vaccine. It’s easier said than done

Politics Sarah Owermohle

After grilling Fauci on Covid origins, House Republicans want to consider new rules for foreign research

Morning Rounds Elizabeth Cooney

Morning Rounds: Our newsroom’s favorite stories of 2023

The Readout Meghana Keshavan

Inhaled vaccines could stop Covid infections, monkey studies show

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility

The Readout Meghana Keshavan

CRISPR is about to make history. Here’s the 5-minute rundown of what to expect